logo
Japan's oldest person is a 114-year-old retired doctor who carried an Olympic torch in 2021

Japan's oldest person is a 114-year-old retired doctor who carried an Olympic torch in 2021

Toronto Star2 days ago
TOKYO (AP) — Shigeko Kagawa, a 114-year-old retired physician from Nara Prefecture, has became Japan's oldest living person, following the death of 114-year-old Miyoko Hiroyasu, according to Japan's Ministry of Health, Labor and Welfare.
Kagawa, a symbol of Japan's extraordinary longevity, graduated from medical school before World War II, served at a hospital in Osaka during the war, and later ran her family's clinic as an obstetrician and gynecologist. She retired at 86.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Veterans Affairs Canada (VAC) adds Registered Clinical Counsellors (RCCs) to approved providers list
Veterans Affairs Canada (VAC) adds Registered Clinical Counsellors (RCCs) to approved providers list

Cision Canada

time2 hours ago

  • Cision Canada

Veterans Affairs Canada (VAC) adds Registered Clinical Counsellors (RCCs) to approved providers list

Change expands access to mental health care for Canada's 461,240 veterans VICTORIA, BC, Aug. 6, 2025 /CNW/ - Veterans Affairs Canada (VAC) has officially approved Registered Clinical Counsellors (RCCs) as eligible health service providers for veterans, expanding access to timely and specialized mental health care. With over 9,000 RCCs across British Columbia, this change will significantly increase options for veterans seeking support. To qualify as VAC providers, applicants must be registered members in good standing with the BC Association of Clinical Counsellors (BCACC), have an unrestricted registration, demonstrate 5 years of clinical counselling experience, and specialize in the following fields: Individual and Family Counselling Depressive Disorders Post-Traumatic Stress Disorder (PTSD) Anxiety Disorders Adjustment and Bipolar Disorders Chronic Pain Addiction Counselling Life and Transition Skills According to the 2021 census, Canada is home to 461,240 veterans, representing 1.5% of the Canadian population. BC has approximately 63,845 veterans from the Canadian Armed Forces and those who served in World War II and the Korean War. Demand for mental health services among Canada's veterans has been on the rise. A study found that nearly 31% of female veterans and 23% of male veterans consulted a mental health professional in one year, a rate double that of the civilian population. 70% of veterans who receive disability benefits from a mental health condition have PTSD. The COVID-19 pandemic exacerbated the situation with 56% of veterans reporting worse mental health than before the pandemic. Canadian veterans are more likely to self-report a mental health condition than members of the Canadian general population. This is where access plays a crucial role. "With the inclusion of Registered Clinical Counsellors, Veterans Affairs Canada has significantly expanded its provider network in B.C." says BCACC CEO, Michael Radano. "This will immediately reduce wait-times and improve client-clinician fit for veterans. This move increases access to appropriate care and specialists trained to work with military personnel and first responders, along with a large cohort of trauma-informed practitioners. It also reflects the high regard the RCC designation holds across Canada as a mark of professional excellence and trusted clinical care." BCACC currently has 9,000+ Registered Clinical Counsellors (RCCs) who comprise approximately 90% of British Columbia's clinical counsellors. BCACC: The BC Association of Clinical Counsellors (BCACC) is a not-for-profit provincial professional association founded in 1988 with more than 10,000 members. BCACC advocates for the clinical counselling/psychotherapy profession and public access to mental health services. Its 9000+ Registered Clinical Counsellors (RCCs) are held to the highest standards of practice and a strict code of ethics in service and protection of the public which includes a robust complaint, inquiry, and remedial process.

What to know about mRNA vaccines
What to know about mRNA vaccines

Toronto Star

time3 hours ago

  • Toronto Star

What to know about mRNA vaccines

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and treatments against a long list of diseases including cancer and cystic fibrosis. But this week, U.S. Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic, canceled $500 million in government-funded research projects to create new mRNA vaccines against respiratory illnesses that might trigger another health emergency.

What to know about mRNA vaccines
What to know about mRNA vaccines

Winnipeg Free Press

time3 hours ago

  • Winnipeg Free Press

What to know about mRNA vaccines

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and treatments against a long list of diseases including cancer and cystic fibrosis. But this week, U.S. Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic, canceled $500 million in government-funded research projects to create new mRNA vaccines against respiratory illnesses that might trigger another health emergency. That dismays infectious disease experts who note that mRNA allows faster production of shots than older vaccine-production methods, buying precious time if another pandemic were to emerge. Using older technology to target a pandemic flu strain would take 18 months to 'make enough vaccine to vaccinate only about one-fourth of the world,' said Michael Osterholm of the University of Minnesota, an expert on pandemic preparation. But using mRNA technology 'could change that dramatically, such that by the end of the first year, we could vaccinate the world.' How mRNA technology works Traditionally, making vaccines required growing viruses or pieces of viruses called proteins — often in giant vats of cells or, like most flu shots, in chicken eggs — and then purifying them. Injecting a small dose as a vaccine trains the body how to recognize when a real infection hits so it's ready to fight back. But that technology takes a long time. Using mRNA is a faster process. The 'm' stands for messenger, meaning mRNA carries instructions for our bodies to make proteins. Scientists figured out how to harness that natural process by making mRNA in a lab. They take a snippet of that genetic code that carries instructions for making the protein they want the vaccine to target. Injecting that snippet instructs the body to become its own mini-vaccine factory, making enough copies of the protein for the immune system to recognize and react. The COVID-19 vaccines aren't perfect Years of research show protection from COVID-19 vaccines — both the types made with mRNA and a type made with traditional technology — does wane over time. The vaccinations provide the strongest protection against severe infection and death, even if people still become infected. But that's a common feature with both the coronavirus and flu because both viruses continually mutate. That's the reason we're told to get a flu vaccine every year — using vaccines made with traditional methods, not mRNA. Today's COVID-19 vaccines made with mRNA by Pfizer and Moderna can be updated more quickly each year than traditional types, an advantage that now has multiple companies developing other vaccines using the technology. Traditional vaccines aren't the only use for mRNA Osterholm counts about 15 infectious disease vaccines that could benefit from mRNA technology, but that's not the only potential. Many disease therapies take aim at proteins, making mRNA a potential technique for developing new treatments. Researchers already are testing an mRNA-based therapeutic vaccine for pancreatic cancer. Genetic diseases are another target, such as an experimental inhaled therapy for cystic fibrosis. ___ AP video journalist Nathan Ellgren contributed to this report. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store